An investigation on behalf of investors in Abeona Therapeutics Inc (NASDAQ:ABEO) shares over potential wrongdoing at Abeona Therapeutics Inc was announced and NASDAQ:ABEO stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 06/02/2016 -- An investigation for investors in shares of Abeona Therapeutics Inc (NASDAQ:ABEO) was announced over potential breaches of fiduciary duties by certain officers and directors at Abeona Therapeutics.
Investors who purchased shares of Abeona Therapeutics Inc (NASDAQ:ABEO) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Abeona Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.
Dallas, TX based Abeona Therapeutics, Inc. develops and delivers gene therapy and plasma-based products for rare disease. Abeona Therapeutics Inc reported that its annual Total Revenue rose from $.93 million in 2014 to $1.04 million in 2015 and that its Net Loss declined from $26.78 million in 2014 to $14.53 million in 2015.
Shares of Abeona Therapeutics Inc (NASDAQ:ABEO) declined from $8.76 per share in May 2015 to as low as $2.05 per share on March 1, 2016.
On June 1, 2016, NASDAQ:ABEO shares closed at $2.99 per share.
Those who purchased shares of Abeona Therapeutics Inc have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego